Cargando…

New insights into the pathophysiology and clinical care of rare primary liver cancers

Hepatocholangiocarcinoma, fibrolamellar carcinoma, hepatic haemangioendothelioma and hepatic angiosarcoma represent less than 5% of primary liver cancers. Fibrolamellar carcinoma and hepatic haemangioendothelioma are driven by unique somatic genetic alterations (DNAJB1-PRKCA and CAMTA1-WWTR1 fusions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gigante, Elia, Paradis, Valérie, Ronot, Maxime, Cauchy, François, Soubrane, Olivier, Ganne-Carrié, Nathalie, Nault, Jean-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653076/ https://www.ncbi.nlm.nih.gov/pubmed/33205035 http://dx.doi.org/10.1016/j.jhepr.2020.100174

Ejemplares similares

Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma
por: Souhami, Alexandra, et al.
Publicado: (2020)

Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas
por: Chopinet, Sophie, et al.
Publicado: (2021)

Colorectal liver metastases: radiopathological correlation
por: Paulatto, Luisa, et al.
Publicado: (2020)

Reply to: “Malignant transformation of hepatocellular adenoma”
por: Chopinet, Sophie, et al.
Publicado: (2022)

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
por: Sidali, Sabrina, et al.
Publicado: (2023)

Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI
por: Michallek, Florian, et al.
Publicado: (2022)

Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
por: Roth, Gael, et al.
Publicado: (2022)

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
por: Gigante, Elia, et al.
Publicado: (2022)

Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis
por: Hobeika, Christian, et al.
Publicado: (2020)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation
por: Gigante, Elia, et al.
Publicado: (2022)

Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome
por: Laouirem, Samira, et al.
Publicado: (2018)

Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures
por: Bissonnette, Julien, et al.
Publicado: (2022)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Roth, Gaël S., et al.
Publicado: (2021)

Viscoelastic Parameters for Quantifying Liver Fibrosis: Three-Dimensional Multifrequency MR Elastography Study on Thin Liver Rat Slices
por: Ronot, Maxime, et al.
Publicado: (2014)

Imaging-guided interventions modulating portal venous flow: Evidence and controversies
por: Cannella, Roberto, et al.
Publicado: (2022)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Evaluation of liver tumour response by imaging
por: Gregory, Jules, et al.
Publicado: (2020)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma
por: Mouhoubi, Nesrine, et al.
Publicado: (2022)

MALDI Imaging, a Powerful Multiplex Approach to Decipher Intratumoral Heterogeneity: Combined Hepato-Cholangiocarcinomas as Proof of Concept
por: Gigante, Elia, et al.
Publicado: (2023)

Management of splanchnic vein thrombosis
por: Elkrief, Laure, et al.
Publicado: (2023)

Extrahepatic Portal Hypertension following Liver Transplantation: a Rare but Challenging Problem
por: Malassagne, B., et al.
Publicado: (1998)

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
por: Amaddeo, Giuliana, et al.
Publicado: (2020)

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma
por: Rochigneux, Philippe, et al.
Publicado: (2019)

Cystic liver lesions: a pictorial review
por: Chenin, Mégane, et al.
Publicado: (2022)

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
por: Nahon, Pierre, et al.
Publicado: (2021)

Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2020)

Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France
por: Loffroy, Romaric, et al.
Publicado: (2020)

Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
por: Zappa, Magaly, et al.
Publicado: (2017)

Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot
por: Turco, Célia, et al.
Publicado: (2021)

Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
por: Bioletto, Fabio, et al.
Publicado: (2022)

Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures
por: Crunelli, Vincenzo, et al.
Publicado: (2020)

Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma
por: Hobeika, Christian, et al.
Publicado: (2022)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

Feasibility, safety and accuracy of a CT-guided robotic assistance for percutaneous needle placement in a swine liver model
por: Guiu, Boris, et al.
Publicado: (2021)

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
por: Singh, Anurag, et al.
Publicado: (2021)

Practical model to identify liver transplant recipients at low risk of postoperative haemorrhage, bile leakage and ascites
por: Hobeika, C, et al.
Publicado: (2021)

Author Correction: Feasibility, safety and accuracy of a CT-guided robotic assistance for percutaneous needle placement in a swine liver model
por: Guiu, Boris, et al.
Publicado: (2021)

Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential
por: Sun, Hai-Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t93me21bhdrdrgksobd60lii92